Received Aug 25, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
he developed hives all over his body; very itchy; This non-serious case was reported by a consumer via call center representative and described the occurrence of hives in a elderly male patient who received Herpes zoster (Shingrix) for prophylaxis. The patient's past medical history included blood pressure high. Concurrent medical conditions included diabetes. Concomitant products included aspirin, cimetidine (Zita), carvedilol, losartan, vitamin c, magnesium oxide and evolocumab (Repatha). In JUN-2025, the patient received Shingrix. In JUN-2025, 1 day after receiving Shingrix, the patient experienced hives (Verbatim: he developed hives all over his body) and pruritus (Verbatim: very itchy). The outcome of the hives and pruritus were resolved. It was unknown if the reporter considered the hives and pruritus to be related to Shingrix. It was unknown if the company considered the hives and pruritus to be related to Shingrix. Additional Information: GSK Receipt Date: 15-AUG-2025 The patient received Vitamin d as concomitantly. The patient reported that the next day after he received Shingrix he developed hives all over his body and was very itch.
Diabetes
Medical History/Concurrent Conditions: Blood pressure high
ASPIRIN; Zita; CARVEDILOL; LOSARTAN; VITAMIN C; MAGNESIUM OXIDE; REPATHA